An engaging, inclusive history of the NHS, exploring its surprising survival--and the people who have kept it running In recent decades, a wave of appreciation for the NHS has swept across the UK. Britons have clapped for frontline workers and championed the service as a distinctive national achievement. All this has happened in the face of ideological opposition, marketization, and workforce crises. But how did the NHS become what it is today? In this wide-ranging history, Andrew Seaton examines the full story of the NHS. He traces how the service has changed and adapted, bringing together the experiences of patients, staff from Britain and abroad, and the service's wider supporters and opponents. He explains not only why it survived the neoliberalism of the late twentieth century but also how it became a key marker of national identity. Seaton emphasizes the resilience of the NHS--perpetually "in crisis" and yet perennially enduring--as well as the political values it embodies and the work of those who have tirelessly kept it afloat.

"A concise text providing discussion of the law and an overview of the ethical perspectives, ensuring that readers are able to fully understand the law and its context. Jonathan Herring's lively and captivating writing style brings this highly topical aspect of law to life, whilst remaining closely tailored to course requirements ensuring that this book is the perfect study companion. Carefully created features throughout the text draw attention to the many diverging opinions in medical law, including: religious, feminist, and European perspectives to ensure that readers develop a fully rounded appreciation of the complexities of the subject. As the most regularly updated medical law text, you can be confident that the book takes account of the most recent developments in this extremely fast moving subject area."--Publisher's website

Health Care, Ethics and Insurance provides an essential survey of the key ethical issues in health insurance, providing valuable reading for students and teachers of business studies as well as health professionals.

This is the 4th report from the Health Committee in the 2008-09 session (HCP 194-I, ISBN 9780215530110) and examines the issue of top-up fees in relation to NHS patients wishing to buy additional drugs privately. In June 2008, the Secretary of State appointed Professor Mike Richards, National Clinical Director for Cancer to examine the availability of NHS medicines and to provide guidance on the circumstances where patients should be able to purchase additional drugs not funded by the NHS, see: (http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_089927?IdcService=GET_FILE&dID=176353&Rendition=Web). As a consequence the Department of Health and NICE set out three decisions to implement the recommendations, including: (i) NHS trusts were told to end immediately the practice of withdrawing NHS treatment from patients who purchased drugs privately; (ii) guidance was provided to NHS trusts where patients continued to purchase private drugs; (iii) supplementary guidance was issued to NICE to make available a greater range of more expensive drugs to a greater number of NHS patients. Although the Health Committee welcomes the above new approaches, it also sees certain consequences, in particular the development of a two-tier health system. The Committee, for example believes it would be wrong for very seriously ill patients to be moved from an NHS ward to a different location so as to administer a privately paid drug. Another potential danger, is that two patients with identical conditions in the same NHS ward receive different treatments because one patient could afford it and the other could not. The Committee believes good continuity of care between the NHS and the private sector is therefore essential in this area. Overall the Committee is not convinced that a two-tier system will not develop, and that the Department of Health needs to monitor the implementation of Professor Richard's recommendations.

Includes a statistical series section which provides economic information on the Nation's savings and homefinancing industry.

What does the UK's exit from the EU mean for health and the NHS? This book explains the legal and practical implications of Brexit on the NHS: its staffing; especially on the island of Ireland; medicines, medical devices and equipment; and biomedical research. It considers the UK's post-Brexit trade agreements and what they mean for health, and discusses the effects of the COVID-19 pandemic on post-Brexit health law. To put the legal analysis in context, the book draws on over 400 conversations the authors had with people in the north of England and Northern Ireland, interviews with over 40 health policy stakeholders, details of a film about their research made with ShoutOut UK, the authors' work with Parliaments and governments across the UK, and their collaborations with key actors like the NHS Confederation, the British Medical Association, and Cancer Research UK. The book shows that the language people use to talk about hoped-for legitimate post-Brexit health governance suggests a great deal of faith in law and legal process among 'ordinary people', but the opposite from 'insider elites'. Not What The Bus Promised puts the authors' knowledge and experiences centre frame, rather than claiming to express 'objective reality'. It will be of interest to any reader who cares about the NHS and wants to understand its present and future.

The book provides a critical contribution, looking at the development of social ad health services. Though discussing also contemporary issues, the focus is a more fundamental critique, dismantling the ideological questions that are behind these developments, standing in the context of the critique of capitalism and modernisation. In addition, one contribution looks in particular at the development of human resources in the UK and in another contribution an analysis of empirical data is provided - it looks at the perspective from EU-NGOs active in the sector of social service provision. The book concludes with a contribution compiled by an informal network of various EU-NGOs, looking in an exemplary way at difficulties faced by the recent developments of marketisation and liberalisation.

Medicines Management: A Problem-Based Approach uses patient scenarios to explore pharmacology and medicines management.The book provides the pharmacological background, and examines the other factors, which enable nurses to provide care to the patient. It will equip the new nurse with the skills they need to problem-solve, prioritise and make decisions while delivering effective care.